MetaCap

Clearmind Medicine (CMND) vs PRF Technologies (PRFX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

PRF Technologies is the larger company by market cap ($1.7 million vs $1.3 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CMND-60.15%PRFX-45.79%
+3%-30%-63%
Oct 7, 20261 yearNov 20, 2026
CMND-60.03%PRFX-45.86%
+3%-30%-63%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CMND versus PRFX key metrics
MetricCMNDPRFX
Share price$2.63$0.4758
Market cap$1.33M$1.66M
1-day change-17.68%-23.68%
EPS (TTM)$-461.20$-4.09
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$17.00K
Net income (latest FY)$-3.86M$-5.02M
Gross margin—-311.76%
Operating margin—-30129.41%
Net margin—-29541.18%
52-week high$649.60$7.95
52-week low$2.63$0.46
Distance from 52-week high-99.60%-94.02%
Average volume55.57K228.55K
Shares outstanding507.40K3.50M
Employees—6
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Clearmind Medicine

CMND stock →

Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression.

Health Care · Biotechnology: Pharmaceutical Preparations

About PRF Technologies

PRFX stock →

PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia.

Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees

CMND vs PRFX FAQ

Which is bigger, Clearmind Medicine or PRF Technologies?

PRF Technologies (PRFX) is larger, with a market capitalization of $1.66M compared with $1.33M for Clearmind Medicine (CMND).

Are Clearmind Medicine and PRF Technologies in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons